$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2016 Q4 Form 10-K Financial Statement

#000156459016030217 Filed on December 14, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2016
Revenue $4.365M $31.25K $200.0K
YoY Change 9878.28% -28.57% -50.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.550M $13.12M $27.10M
YoY Change 3.64% 8.07% 17.32%
% of Gross Profit
Research & Development $9.527M $11.67M $55.30M
YoY Change -7.85% 12.32% 16.99%
% of Gross Profit
Depreciation & Amortization $1.200M $900.0K $1.546M
YoY Change 50.0% 12.5% -32.79%
% of Gross Profit
Operating Expenses $19.27M $19.78M $79.80M
YoY Change -0.61% -21.73% -17.18%
Operating Profit -$14.90M -$21.80M
YoY Change -22.95% -13.62%
Interest Expense $25.15K -$480.0K $0.00
YoY Change -74.95% -187.27% -100.0%
% of Operating Profit
Other Income/Expense, Net $2.816M $60.00K $22.12K
YoY Change 3563.71% -185.71% -94.47%
Pretax Income -$12.09M -$22.22M -$81.72M
YoY Change -37.26% -10.19% -11.08%
Income Tax $0.00 $0.00 $2.400K
% Of Pretax Income
Net Earnings -$12.09M -$22.22M -$81.72M
YoY Change -37.26% -10.2% -11.11%
Net Earnings / Revenue -276.86% -71110.35% -40861.5%
Basic Earnings Per Share
Diluted Earnings Per Share -$169.2K -$342.3K -$1.337M
COMMON SHARES
Basic Shares Outstanding 74.17M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $102.1M $85.40M $85.40M
YoY Change 33.29% -13.56% -13.56%
Cash & Equivalents $102.1M $85.37M $85.40M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $3.495M $3.771M $5.100M
YoY Change -38.68% 357.88% 24.39%
Inventory
Prepaid Expenses $569.4K $1.290M
Receivables $100.0K $75.00K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $106.2M $90.50M $90.50M
YoY Change 29.04% -12.03% -12.05%
LONG-TERM ASSETS
Property, Plant & Equipment $16.20M $15.40M $15.40M
YoY Change 244.68% 240.19% 242.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $122.3K $122.3K $100.0K
YoY Change 167.17%
Total Long-Term Assets $38.06M $37.70M $37.70M
YoY Change 30.78% 28.25% 28.23%
TOTAL ASSETS
Total Short-Term Assets $106.2M $90.50M $90.50M
Total Long-Term Assets $38.06M $37.70M $37.70M
Total Assets $144.3M $128.2M $128.2M
YoY Change 29.5% -3.08% -3.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.698M $12.20M $12.20M
YoY Change -30.22% 142.46% 144.0%
Accrued Expenses $4.762M $8.600M $8.600M
YoY Change -10.15% 59.97% -6.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K $200.0K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $37.00M $25.64M $25.60M
YoY Change 200.13% 61.28% 61.01%
LONG-TERM LIABILITIES
Long-Term Debt $2.500M $2.500M $2.500M
YoY Change 400.0% 400.0% 400.0%
Other Long-Term Liabilities $7.600M $200.0K $5.000M
YoY Change 2159.03% 0.0% -19.35%
Total Long-Term Liabilities $10.10M $7.508M $7.500M
YoY Change 51.09% 11.31% 11.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.00M $25.64M $25.60M
Total Long-Term Liabilities $10.10M $7.508M $7.500M
Total Liabilities $46.50M $33.15M $32.60M
YoY Change 144.57% 46.39% 47.51%
SHAREHOLDERS EQUITY
Retained Earnings -$398.4M
YoY Change 25.8%
Common Stock $162.1K
YoY Change 6.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $97.80M $95.58M $95.60M
YoY Change
Total Liabilities & Shareholders Equity $144.3M $128.2M $128.2M
YoY Change 29.56% -3.09% -3.1%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2016
OPERATING ACTIVITIES
Net Income -$12.09M -$22.22M -$81.72M
YoY Change -37.26% -10.2% -11.11%
Depreciation, Depletion And Amortization $1.200M $900.0K $1.546M
YoY Change 50.0% 12.5% -32.79%
Cash From Operating Activities $10.00M -$10.20M -$64.43M
YoY Change -147.39% -15.0% -1.94%
INVESTING ACTIVITIES
Capital Expenditures $5.297M -$2.800M $3.860M
YoY Change 1202.63% 211.11% 95.89%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.000M $17.30M
YoY Change -100.0% -85.07% -33.72%
Cash From Investing Activities -$5.300M -$1.800M $13.45M
YoY Change -303.85% -131.03% -4.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.50M $43.20M $52.23M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.00M 53.60M 55.13M
YoY Change -2500.0% 53500.0% 18277.27%
NET CHANGE
Cash From Operating Activities 10.00M -10.20M -64.43M
Cash From Investing Activities -5.300M -1.800M 13.45M
Cash From Financing Activities 12.00M 53.60M 55.13M
Net Change In Cash 16.70M 41.60M 4.152M
YoY Change -187.89% -781.97% -108.09%
FREE CASH FLOW
Cash From Operating Activities $10.00M -$10.20M -$64.43M
Capital Expenditures $5.297M -$2.800M $3.860M
Free Cash Flow $4.703M -$7.400M -$68.29M
YoY Change -121.87% -33.33% 0.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74173484
CY2016Q1 dei Entity Public Float
EntityPublicFloat
290000000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
101870
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
47267361
CY2014 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
23138050
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25734789
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.024
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
133869
CY2016Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
440580
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
122333
CY2014 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1303911
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
165985255
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11595816
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
426873358
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-136425
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
151914
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7449
CY2015Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3293285
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
823620
CY2015Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
17539902
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45789
CY2016Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
2533455
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200000
CY2016Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7508452
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2274997
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200000
CY2015Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6745709
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
16
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
162116
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10232897
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81214354
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-81579128
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5435640
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1402000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
109253
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37187
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6691200
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3850419
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.71
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.12
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.63
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.60
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.22
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12794064
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9265570
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.58
CY2015Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5862464
CY2015Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
142453
CY2016Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2500000
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
16
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
493844909
CY2015 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
10142786
CY2014 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12829355
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2050817
CY2014 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2172387
CY2015 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1891533
CY2014 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2375658
CY2015 us-gaap Operating Expenses
OperatingExpenses
96355976
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-53276286
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5300
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-81723002
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.60
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46933030
CY2014 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
10148044
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2730000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5696173
CY2014 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
5956079
CY2015 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
401876
CY2015 arwr Exchange Rights Exercised During Period Value
ExchangeRightsExercisedDuringPeriodValue
3072
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-26029
CY2016 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
3691398
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-670765
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
11595816
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
10232897
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
5696173
CY2016 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
231902
CY2015 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1110524
CY2014 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
793887
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
84721
CY2014 arwr Non Cash Gain On Equity Investment
NonCashGainOnEquityInvestment
87197
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
75000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-75000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1020734
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3485421
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
54966
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5000000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2554802
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2497804
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1412275
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-871833
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4435784
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3478094
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
131143
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-40385
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
94257
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-64427486
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-65707615
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-35416373
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3860237
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1970612
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1717362
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
500
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000
CY2014 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
46365528
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
17308000
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
26090950
CY2014 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11591120
CY2015 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
10000000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
13447763
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
14120838
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-36481770
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
217549
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
213991
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
225406
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
634187
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52231433
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
172641671
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1714313
CY2016 arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
3752120
CY2015 arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
504512
CY2014 arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
12878044
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
55131817
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
290521
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
185294309
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4152094
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-51296256
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
113396166
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132510610
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19114444
CY2016 us-gaap Interest Paid
InterestPaid
11287
CY2015 us-gaap Interest Paid
InterestPaid
14429
CY2014 us-gaap Interest Paid
InterestPaid
25635
CY2016 arwr Property And Equipment Purchased Through Tenant Improvement Allowance Financing
PropertyAndEquipmentPurchasedThroughTenantImprovementAllowanceFinancing
4849360
CY2016 arwr Property And Equipment Expenditures Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentExpendituresIncludedInAccountsPayableAndAccruedExpenses
4801930
CY2016 arwr Proceeds From Refundable Income Tax Credits
ProceedsFromRefundableIncomeTaxCredits
1365288
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
5862
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains several bank accounts at two financial institutions for its operations. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per institution. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p></div>
CY2016Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
11885365
CY2015Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3117537
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19899521
CY2015Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
944935
CY2016 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
944935
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23879181
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22164868
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
944935
CY2016Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2016Q3 arwr Threshold Percentage Of Common Stock Ownership Upon Preferred Stock Conversion
ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion
0.0999
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
528181
CY2016 arwr Facility Rent Expense
FacilityRentExpense
839000
CY2015 arwr Facility Rent Expense
FacilityRentExpense
744000
CY2014 arwr Facility Rent Expense
FacilityRentExpense
554000
CY2015Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
110428
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1559259
CY2016Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43200000
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2016Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
442915
CY2015Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
404964
CY2016Q3 arwr Research Equipment
ResearchEquipment
7490400
CY2015Q3 arwr Research Equipment
ResearchEquipment
6354584
CY2016Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
80841
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9987513
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4512760
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5460665
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1046571
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
54653
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700429
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700429
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700429
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700429
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700429
CY2016Q3 arwr Finite Lived Intangible Assets Amortization Expense Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseYearSix
1700429
CY2016Q3 arwr Finite Lived Intangible Assets Amortization Expense After Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix
11962294
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1531765
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1435409
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1044431
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1070496
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
5766495
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
12407855
CY2016Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
194310
CY2016Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
208506
CY2016Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
223820
CY2016Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
240258
CY2016Q3 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
257903
CY2016Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
1602968
CY2016Q3 us-gaap Contractual Obligation
ContractualObligation
2727765
CY2016Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2016Q3 us-gaap Purchase Obligation
PurchaseObligation
10400000
CY2016Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
10400000
CY2016Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
0
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.56
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0105
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0146
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.018
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0189
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0189
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.89
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.24
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.92
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each RSU will be exchanged for one share of the Company’s Common Stock. Restricted stock unit awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-293072
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2684712
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5821796
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1691050
CY2015Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1513021
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7224958
CY2015Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6571774
CY2016Q3 arwr Deferred Tax Assets In Process Research And Development Cost
DeferredTaxAssetsInProcessResearchAndDevelopmentCost
2957528
CY2015Q3 arwr Deferred Tax Asset Fair Value Adjustments
DeferredTaxAssetFairValueAdjustments
2850125
CY2016Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
125120957
CY2015Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
88965968
CY2016Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
5544091
CY2015Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
5551705
CY2016Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
142538584
CY2015Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
105452593
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
128695371
CY2015Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95085045
CY2016Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
13804268
CY2015Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
10282834
CY2016Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
38945
CY2015Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
84714
CY2016Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13843213
CY2015Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10367548
CY2016Q3 arwr Percentage Of Valuation Allowance
PercentageOfValuationAllowance
1.00
CY2015Q3 arwr Federal Net Operating Loss Carry Forward
FederalNetOperatingLossCarryForward
185100000
CY2016 arwr Federal Estimated Net Operating Loss Carry Forward
FederalEstimatedNetOperatingLossCarryForward
78700000
CY2015Q3 arwr State Net Operating Loss Carry Forwards
StateNetOperatingLossCarryForwards
285400000
CY2016 arwr State Estimated Net Operating Loss Carry Forward
StateEstimatedNetOperatingLossCarryForward
133900000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400
CY2016 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2400
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2400
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.090
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.093
CY2016 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
0.011
CY2015 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
0.007
CY2016 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
-0.001
CY2015 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.007
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.411
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.434
CY2016 arwr Effective Income Tax Rate Reconciliation Nondeductible Income Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleIncomeExpenseOther
-0.007
CY2015 arwr Effective Income Tax Rate Reconciliation Nondeductible Income Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleIncomeExpenseOther
0.001
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
476835
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
407603
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
264193
CY2015Q4 us-gaap Revenues
Revenues
43750
CY2016Q1 us-gaap Revenues
Revenues
43750
CY2016Q2 us-gaap Revenues
Revenues
39583
CY2016Q3 us-gaap Revenues
Revenues
31250
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-19341270
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-21264855
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19341487
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21795114
CY2015Q4 us-gaap Profit Loss
ProfitLoss
-19264414
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-20815860
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-19420743
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-22221985
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-19264414
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-20815860
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-19420743
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-22221985
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2014Q4 us-gaap Revenues
Revenues
170750
CY2015Q1 us-gaap Revenues
Revenues
43750
CY2015Q2 us-gaap Revenues
Revenues
123750
CY2015Q3 us-gaap Revenues
Revenues
43750
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-25115276
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-29632743
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15993706
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25232251
CY2014Q4 us-gaap Profit Loss
ProfitLoss
-22575282
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-28683993
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-15936053
CY2015Q3 us-gaap Profit Loss
ProfitLoss
-24745554
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-22575282
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-28683993
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-15936053
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-24745554
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42

Files In Submission

Name View Source Status
0001564590-16-030217-index-headers.html Edgar Link pending
0001564590-16-030217-index.html Edgar Link pending
0001564590-16-030217.txt Edgar Link pending
0001564590-16-030217-xbrl.zip Edgar Link pending
arwr-10k_20160930.htm Edgar Link pending
arwr-20160930.xml Edgar Link completed
arwr-20160930.xsd Edgar Link pending
arwr-20160930_cal.xml Edgar Link unprocessable
arwr-20160930_def.xml Edgar Link unprocessable
arwr-20160930_lab.xml Edgar Link unprocessable
arwr-20160930_pre.xml Edgar Link unprocessable
arwr-ex1018_310.htm Edgar Link pending
arwr-ex1019_309.htm Edgar Link pending
arwr-ex211_308.htm Edgar Link pending
arwr-ex231_307.htm Edgar Link pending
arwr-ex311_8.htm Edgar Link pending
arwr-ex312_6.htm Edgar Link pending
arwr-ex321_7.htm Edgar Link pending
arwr-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g20161214192231699791.jpg Edgar Link pending
g20161214192232007792.jpg Edgar Link pending
g20161214192232027793.jpg Edgar Link pending
g20161214192232033794.jpg Edgar Link pending
g20161214192232038795.jpg Edgar Link pending
g20161214192234482796.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending